Returning to Work After Rehab: A Practical Guide to the First 90 Days

The ninety days after you return to work from residential treatment is the window where the statistics decide. Relapse rates are highest in the first three months post-discharge — somewhere between 40 and 60 percent across most published outcome studies, depending on substance and cohort. The rates are not destiny; they are statistics. But the window is real, and the things that happen at work during it matter more than most aftercare plans acknowledge.

This is a practical guide to those ninety days, written for the person returning to their job — not for an employer, not for an HR consultant, not as a general survey. It assumes you have completed a residential or intensive outpatient program, that you have an aftercare plan in place, and that your job has been waiting for you. It focuses on the non-clinical stuff: what to disclose, what not to, how to manage a workday that now has a different shape, and what to do when you feel yourself slipping.

The first question: what does your job know already?

Before you plan the return, get clear on what your employer and your colleagues actually know. There are typically three categories.

If you took Family and Medical Leave Act (FMLA) leave for treatment, your HR department knows you had a qualifying medical condition, but — crucially — FMLA does not require you to disclose the specific diagnosis. Most HR departments know only that you were on approved medical leave. Your manager may or may not know more, depending on the size of the company and whether HR routes specific information or just coverage details.

If you used short-term disability, the disability carrier has your clinical information, and the employer may have been told that you had a qualifying behavioral-health condition. The employer does not have your medical records.

If your leave was informal — a vacation, a personal leave, an unexplained absence — then the company knows nothing specifically. Your colleagues will have speculation, and the speculation will fill the vacuum left by your silence. That is not necessarily bad, but it shapes the return.

Before your first day back, call HR or your manager and get clear on two things: what is on record as the reason for your absence, and who has seen it. You can decide what to disclose to individual colleagues only after you know what the institutional record says.

Whether to disclose, and to whom

This is the most-asked question in employment-after-treatment and there is no universal answer. The research literature is muddy — disclosure produces better long-term outcomes in some studies, worse in others, and the difference is usually explained by how supportive the workplace environment actually is. The useful framing is not "should I disclose?" but "whom, how much, and why."

Your manager. Usually yes, but not necessarily in detail. A manager who knows you are in recovery can accommodate an aftercare appointment schedule without questioning it; a manager who does not know will question why you are leaving early every Tuesday afternoon. Most employment counselors recommend telling the direct manager in functional terms: "I recently completed treatment for a medical condition that requires ongoing outpatient appointments. I will need flexibility for [X time per week]. The condition does not affect my ability to perform the job; it does mean I have some fixed appointments I cannot move." You are not obligated to say "addiction." You are also not prohibited from saying it. Read the manager.

HR. Generally yes, and you are typically protected by the Americans with Disabilities Act (ADA) when you disclose a substance use disorder in recovery to HR. Active use is not protected by the ADA; recovery is. Disclosure to HR triggers the employer's duty to consider reasonable accommodations.

Peers and colleagues. Highly variable, mostly your call, often regrettable if done in the first 30 days. Many people who disclose early regret the early disclosure because colleagues — even well-meaning ones — will behave differently around them, make assumptions, or share the information with other colleagues. Many people who disclose at 6-12 months regret nothing. The pattern, roughly: the more stable your recovery, the less you need to disclose for yourself and the more you can disclose for others (being visibly in recovery is its own kind of useful modeling). Rushed disclosures in the first three months tend to serve anxiety rather than recovery.

The schedule problem

Your aftercare schedule is probably more demanding than your pre-treatment life was. If you are in outpatient therapy once or twice a week, attending 12-step or SMART Recovery meetings 3-5 times a week, seeing a medication prescriber monthly, and doing urine-toxicology screens on some cadence, the time commitment can easily run 8-15 hours a week outside of work.

Three practical moves.

First: bloc the aftercare time before work commitments fill the calendar. Put the Tuesday therapy appointment on the calendar as "recurring personal appointment" and treat it as immovable. Meetings and conference calls that try to land on it should be moved or declined, not rescheduled. The habit of protecting recovery time is a skill you are building; undermining it in week one sets a precedent.

Second: do not take on new work responsibilities in the first 60 days. There is a natural impulse to prove to yourself and your team that you are back and fine. The impulse is usually wrong. Returning at your pre-leave responsibility level, maybe slightly below it, gives you margin for the cognitive and emotional work that recovery still requires. You can take on new things in month three or four.

Third: plan your work-to-home transition. The hour between leaving the office and arriving home used to include — or include the need for — substance use. It is worth giving that hour a new structure: a gym visit, a podcast, a brief meeting, a specific route home. Blank unstructured time is the riskiest hour in an early-recovery day, and the drive home is often that hour.

The social problem

If alcohol or substances were part of your work social culture — the drinks after meetings, the Thursday bar night, the client dinners, the conference open bar — you are about to navigate a set of expectations that were built around the earlier you. Three options:

Go but do not drink. This works well when the social dynamic is the point and the drinking is incidental. Order a seltzer with lime. Most colleagues will not notice. The ones who do notice and ask are the ones you can tell you are cutting back, taking a break, or doing Dry January for a few months. Brevity is fine; you do not owe an explanation.

Go for part of it. Show up for the meal portion of the client dinner, stay for 45 minutes, leave before the second round of drinks arrives. Showing up at all preserves the relationship; leaving early protects your night.

Decline for the first 60 days. Especially for events that were particularly high-risk in your use pattern. "I have a scheduling conflict" works for most things. You will get invited again. Missing a few events in the first two months post-treatment is a well-spent price.

The option you want to avoid, clinically, is attending high-risk events in the first 60 days out of professional anxiety. The data on relapse triggers is consistent that the first 60-90 days are the period of highest vulnerability, and workplace-social events are common triggers.

Medications and work

If your treatment involved medication-assisted treatment (MAT) — buprenorphine, methadone, naltrexone — the workplace question is two questions. One: is your performance affected? Answer: for most people on stable MAT dosing, no. MAT medications do not impair cognitive function, do not produce a high, and do not show up in standard 5-panel workplace drug screens (methadone and buprenorphine require specific panels to detect). Two: does your employer need to know? Answer: generally no, unless you are in a safety-sensitive position (DOT-regulated driving, airline pilot, specific federal positions) where disclosure obligations exist. Check your employer's drug-testing policy; the policy will tell you what panel they run and what the reporting requirements are.

If you are concerned about a workplace drug screen returning unexpected results, get a letter from your prescribing physician documenting the medication. The Medical Review Officer (MRO) who processes positive drug screens is required by federal regulations to consider legitimate prescriptions before reporting the result to the employer. A positive result for buprenorphine with a physician letter reaches the employer as "no action required," not "failed drug screen."

When you feel yourself slipping

This is the hardest part of the guide to write and the most important. Most relapses do not begin with the decision to use. They begin with the gradual weakening of recovery structure — skipped meetings, missed therapy appointments, reduced contact with sponsor, increased isolation, emotional states (HALT: hungry, angry, lonely, tired) that go unaddressed. The workplace amplifies all of these if you are not watching.

Three warning signs that matter professionally.

The return of old work patterns. If you were a late-night-at-the-office person, or a skip-lunch-to-push-through person, or a wine-with-laptop-after-dinner person, and you find yourself back in those patterns, that is a signal. Pre-treatment behavioral patterns tend to correlate with substance use; post-treatment they can be early warning signs.

The shortening of the aftercare calendar. When the Tuesday therapy appointment gets rescheduled for a work emergency, then rescheduled again, then dropped, that is almost never about work. That is about recovery motivation weakening, and work is providing cover. Notice it when it happens the second time, not the fifth.

The narrowing of support contact. If you were in regular contact with a sponsor, a counselor, or a recovery peer group and that contact has thinned, call. Even when — especially when — you feel you do not need to.

If you do use, call your outpatient counselor and your sponsor before you call work. Most relapses are not career-ending if they are caught early and addressed openly. Most relapses that become career-ending were hidden, extended, and discovered by the employer rather than disclosed by the person. An honest conversation with HR about a slip, delivered in week one of the slip, often produces a leave of absence and a return-to-work plan. The same slip discovered by the employer in week six often produces a termination.

The 90-day mark

If you make it to day 90 working full-time with aftercare intact, you have done the statistically hardest thing. The next 90 days are easier, and the 90 after that are easier still. The first 90 are where most people either consolidate the recovery or lose it, and they are consolidated less by a single good decision than by the accumulation of small unglamorous ones: blocking the therapy appointment, declining the drink, leaving the dinner early, calling the sponsor, taking the second cup of coffee instead of the first beer.

The bar for "success" in the first 90 days is not "triumphant return to full productivity." The bar is: present at work, aftercare intact, relationships preserved. If that is where you are on day 91, you have done well. Measure against that bar, not the bar your pre-treatment self would have used.

Sources

1. SAMHSA. TIP 62: Clients with Substance Use Disorders and Vocational Rehabilitation. store.samhsa.gov
2. U.S. Department of Labor. Americans with Disabilities Act (ADA) protections for individuals in recovery.
3. FMLA. Family and Medical Leave Act, 29 U.S.C. §§ 2601–2654 — qualifying condition coverage for substance-use treatment.
4. Faces and Voices of Recovery. Workplace-recovery guides and peer resources. facesandvoicesofrecovery.org
5. NIDA. Principles of Drug Addiction Treatment — post-treatment continuing care data and relapse-window statistics.
6. Kelly JF et al. Outcome research on 90-day post-treatment abstinence, various journal publications.